These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17085766)

  • 1. Evaluation of 3-deaza-adenosine analogues as ligands for adenosine kinase and inhibitors of Mycobacterium tuberculosis growth.
    Long MC; Allan PW; Luo MZ; Liu MC; Sartorelli AC; Parker WB
    J Antimicrob Chemother; 2007 Jan; 59(1):118-21. PubMed ID: 17085766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship for nucleoside analogs as inhibitors or substrates of adenosine kinase from Mycobacterium tuberculosis. I. Modifications to the adenine moiety.
    Long MC; Parker WB
    Biochem Pharmacol; 2006 Jun; 71(12):1671-82. PubMed ID: 16620788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of 2-methyladenosine in Mycobacterium tuberculosis.
    Parker WB; Barrow EW; Allan PW; Shaddix SC; Long MC; Barrow WW; Bansal N; Maddry JA
    Tuberculosis (Edinb); 2004; 84(5):327-36. PubMed ID: 15207808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship for adenosine kinase from Mycobacterium tuberculosis II. Modifications to the ribofuranosyl moiety.
    Long MC; Shaddix SC; Moukha-Chafiq O; Maddry JA; Nagy L; Parker WB
    Biochem Pharmacol; 2008 Apr; 75(8):1588-600. PubMed ID: 18329005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of a unique adenosine kinase from Mycobacterium tuberculosis.
    Long MC; Escuyer V; Parker WB
    J Bacteriol; 2003 Nov; 185(22):6548-55. PubMed ID: 14594827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of 7-deaza-6-benzylthioinosine analogues as ligands of Toxoplasma gondii adenosine kinase.
    Kim YA; Sharon A; Chu CK; Rais RH; Al Safarjalani ON; Naguib FN; el Kouni MH
    J Med Chem; 2008 Jul; 51(13):3934-45. PubMed ID: 18563892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-aided design of inhibitors of Mycobacterium tuberculosis thymidylate kinase.
    Van Calenbergh S
    Verh K Acad Geneeskd Belg; 2006; 68(4):223-48. PubMed ID: 17214439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
    Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M
    Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis.
    Castagnolo D; De Logu A; Radi M; Bechi B; Manetti F; Magnani M; Supino S; Meleddu R; Chisu L; Botta M
    Bioorg Med Chem; 2008 Sep; 16(18):8587-91. PubMed ID: 18752962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cordycepin kills Mycobacterium tuberculosis through hijacking the bacterial adenosine kinase.
    Huang F; Li W; Xu H; Qin H; He ZG
    PLoS One; 2019; 14(6):e0218449. PubMed ID: 31199855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based design, synthesis and preliminary evaluation of selective inhibitors of dihydrofolate reductase from Mycobacterium tuberculosis.
    El-Hamamsy MH; Smith AW; Thompson AS; Threadgill MD
    Bioorg Med Chem; 2007 Jul; 15(13):4552-76. PubMed ID: 17451962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring acyclic nucleoside analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase.
    Familiar O; Munier-Lehmann H; Negri A; Gago F; Douguet D; Rigouts L; Hernández AI; Camarasa MJ; Pérez-Pérez MJ
    ChemMedChem; 2008 Jul; 3(7):1083-93. PubMed ID: 18418833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective activity against Mycobacteriumtuberculosis of new quinoxaline 1,4-di-N-oxides.
    Vicente E; Pérez-Silanes S; Lima LM; Ancizu S; Burguete A; Solano B; Villar R; Aldana I; Monge A
    Bioorg Med Chem; 2009 Jan; 17(1):385-9. PubMed ID: 19058970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 7-Deaza-6-benzylthioinosine analogues as subversive substrate of Toxoplasma gondii adenosine kinase: activities and selective toxicities.
    Al Safarjalani ON; Rais RH; Kim YA; Chu CK; Naguib FN; el Kouni MH
    Biochem Pharmacol; 2008 Oct; 76(8):958-66. PubMed ID: 18755159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
    Sasaki H; Haraguchi Y; Itotani M; Kuroda H; Hashizume H; Tomishige T; Kawasaki M; Matsumoto M; Komatsu M; Tsubouchi H
    J Med Chem; 2006 Dec; 49(26):7854-60. PubMed ID: 17181168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
    Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
    Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of new S-derivatives of clubbed triazolyl thiazole as anti-Mycobacterium tuberculosis agents.
    Shiradkar MR; Murahari KK; Gangadasu HR; Suresh T; Kalyan CA; Panchal D; Kaur R; Burange P; Ghogare J; Mokale V; Raut M
    Bioorg Med Chem; 2007 Jun; 15(12):3997-4008. PubMed ID: 17442576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge based identification of potent antitubercular compounds using structure based virtual screening and structure interaction fingerprints.
    Kumar A; Chaturvedi V; Bhatnagar S; Sinha S; Siddiqi MI
    J Chem Inf Model; 2009 Jan; 49(1):35-42. PubMed ID: 19063713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis.
    Kurabachew M; Lu SH; Krastel P; Schmitt EK; Suresh BL; Goh A; Knox JE; Ma NL; Jiricek J; Beer D; Cynamon M; Petersen F; Dartois V; Keller T; Dick T; Sambandamurthy VK
    J Antimicrob Chemother; 2008 Oct; 62(4):713-9. PubMed ID: 18587134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimycobacterial activity of 2-methyl-adenosine.
    Barrow EW; Westbrook L; Bansal N; Suling WJ; Maddry JA; Parker WB; Barrow WW
    J Antimicrob Chemother; 2003 Nov; 52(5):801-8. PubMed ID: 14563890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.